12.38
0.00 (0.00%)
| Previous Close | 12.38 |
| Open | 11.78 |
| Volume | 5,739 |
| Avg. Volume (3M) | 161,333 |
| Market Cap | 7,679,962 |
| Price / Earnings (TTM) | 12.38 |
| Price / Sales | 1.74 |
| Price / Book | 0.980 |
| 52 Weeks Range | |
| Earnings Date | 15 Jun 2025 - 21 Jun 2025 |
| Profit Margin | 0.02% |
| Operating Margin (TTM) | -26.46% |
| Quarterly Revenue Growth (YOY) | 85.30% |
| Total Debt/Equity (MRQ) | 13.92% |
| Current Ratio (MRQ) | 4.91 |
| Operating Cash Flow (TTM) | -1.33 M |
| Levered Free Cash Flow (TTM) | -1.22 M |
| Return on Assets (TTM) | -0.14% |
| Return on Equity (TTM) | 0.01% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (GB) | Mixed | Mixed |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | RUA LIFE SCIENCES PLC ORD 5P | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.63 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| RUA LIFE SCIENCES PLC ORD 5P | 8 M | - | 12.38 | 0.980 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| CREO MEDICAL GROUP PLC ORD GBP0 | 53 M | - | - | 1.22 |
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.600 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 1.13 |
|
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 59.16% |
| % Held by Institutions | 24.92% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |